Related Experiment Video
Updated: Jan 2, 2026
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
Mitchel Tate1,2, Darnel Prakoso1,3, Andrew M Willis1
1Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Insights
This study developed a new animal model for diabetic cardiomyopathy, showing it accurately mimics human heart complications from diabetes. This model aids in understanding disease progression and developing better treatments for diabetic heart conditions.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Heart failure is a growing global health concern, often linked to diabetes.
- Diabetic cardiomyopathy, a specific heart condition in diabetics, lacks effective treatments due to inadequate experimental models.
Purpose of the Study:
- To develop and validate a novel preclinical model that recapitulates long-term diabetic complications, focusing on cardiac dysfunction.
- To investigate the metabolic, renal, hepatic, and cardiac alterations in this new model.
Main Methods:
- A combination of daily low-dose streptozotocin injections and a high-fat diet was administered to induce a diabetic state.
- Animals were assessed at 26 weeks for metabolic changes, organ damage (kidneys, liver), and cardiac function (diastolic and systolic).
- Cardiac structural changes and signaling pathway activation were analyzed.
Main Results:
- The model exhibited key metabolic derangements, including hyperglycemia and altered insulin/C-peptide levels.
- Significant diabetic nephropathy and progressive liver damage were observed.
- Robust left ventricular diastolic dysfunction with preserved systolic function was evident, alongside myocardial fibrosis and activated cardiac signaling pathways.
Conclusions:
- This combined streptozotocin and high-fat diet protocol effectively models long-term diabetic complications, including characteristic cardiac dysfunction.
- The developed model provides a valuable tool for studying the pathophysiology of diabetic cardiomyopathy and evaluating potential therapeutic strategies.
Abstract:
The increasing burden of heart failure globally can be partly attributed to the increased prevalence of diabetes, and the subsequent development of a distinct form of heart failure known as diabetic cardiomyopathy. Despite this, effective treatment options have remained elusive, due partly to the lack of an experimental model that adequately mimics human disease. In the current study, we combined three consecutive daily injections of low-dose streptozotocin with high-fat diet, in order to recapitulate the long-term complications of diabetes, with a specific focus on the diabetic heart. At 26 weeks of diabetes, several metabolic changes were observed including elevated blood glucose, glycated haemoglobin, plasma insulin and plasma C-peptide. Further analysis of organs commonly affected by diabetes revealed diabetic nephropathy, underlined by renal functional and structural abnormalities, as well as progressive liver damage. In addition, this protocol led to robust left ventricular diastolic dysfunction at 26 weeks with preserved systolic function, a key characteristic of patients with type 2 diabetes-induced cardiomyopathy. These observations corresponded with cardiac structural changes, namely an increase in myocardial fibrosis, as well as activation of several cardiac signalling pathways previously implicated in disease progression. It is hoped that development of an appropriate model will help to understand some the pathophysiological mechanisms underlying the accelerated progression of diabetic complications, leading ultimately to more efficacious treatment options.
